Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV n-3 PUFA for SCD Risk in Hemodialysis
NCT00259025Phase 2Completed
- Sponsor
- Aalborg University Hospital
- Start
- Sep 2006
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ventricular arrhythmia (VA) and sudden cardiac death (SCD) comparing n-3 PUFA with Placebo (2 arms). Primary endpoint: Heart rate variability. Started Sep 2006; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
ventricular arrhythmia (VA)sudden cardiac death (SCD)
Beyond the preview
Go deeper on NCT00259025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259025.